Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Armata Pharmaceuticals, Inc. Director's Dealing 2015

Nov 9, 2015

34152_dirs_2015-11-09_4a16041b-1d8b-4eb6-8101-2ab672bad0d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-11-05

Reporting Person: SAMANT VIJAY B (Director)